# Jack Wright

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jack-wright/

## Facts

| Field | Value |
| --- | --- |
| Citations | 312 |
| Field | Amyotrophic Lateral Sclerosis Research |
| h-index | 9 |
| i10-index | 9 |
| Last Known Institution | Adelphi Group (United Kingdom) |
| OpenAlex ID | https://openalex.org/A5034033151 |
| ORCID iD | 0000-0002-7380-9754 |
| Works | 49 |

## Researcher papers

- [Economic Burden of Parkinson’s Disease: A Multinational, Real-World, Cost-of-Illness Study](https://scholariq.org/papers/economic-burden-of-parkinson-s-disease-a-multinational-real-world-cost-of/)
- [Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries](https://scholariq.org/papers/does-the-5-2-1-criteria-identify-patients-with-advanced-parkinson-s-disease-real/)
- [Associations Between Relapses and Psychosocial Outcomes in Patients With Schizophrenia in Real-World Settings in the United States](https://scholariq.org/papers/associations-between-relapses-and-psychosocial-outcomes-in-patients-with/)
- [Real-world assessment of the impact of “OFF” episodes on health-related quality of life among patients with Parkinson’s disease in the United States](https://scholariq.org/papers/real-world-assessment-of-the-impact-of-off-episodes-on-health-related-quality-of/)
- [Treatment Goals in Schizophrenia: A Real-World Survey of Patients, Psychiatrists, and Caregivers in the United States, with an Analysis of Current Treatment (Long-Acting Injectable vs Oral Antipsychotics) and Goal Selection](https://scholariq.org/papers/treatment-goals-in-schizophrenia-a-real-world-survey-of-patients-psychiatrists/)
- [Misdiagnosis of amyotrophic lateral sclerosis in clinical practice in Europe and the USA: a patient chart review and physician survey](https://scholariq.org/papers/misdiagnosis-of-amyotrophic-lateral-sclerosis-in-clinical-practice-in-europe-and/)
- [Healthcare resource utilization and device-aided therapy discussions with eligible patients across the Parkinson's disease continuum: Revelations from the MANAGE-PD validation cohort](https://scholariq.org/papers/healthcare-resource-utilization-and-device-aided-therapy-discussions-with/)
- [Time from amyotrophic lateral sclerosis symptom onset to key disease milestones: analysis of data from a multinational cross-sectional survey](https://scholariq.org/papers/time-from-amyotrophic-lateral-sclerosis-symptom-onset-to-key-disease-milestones/)
- [Real-world assessment of “OFF” episode–related healthcare resource utilization among patients with Parkinson’s disease in the United States](https://scholariq.org/papers/real-world-assessment-of-off-episode-related-healthcare-resource-utilization/)
- [The Burden of Progressive Supranuclear Palsy on Patients, Caregivers, and Healthcare Systems by PSP Phenotype: A Cross-Sectional Study](https://scholariq.org/papers/the-burden-of-progressive-supranuclear-palsy-on-patients-caregivers-and/)
- [Healthcare resource utilization at different stages of amyotrophic lateral sclerosis: Results from a real-world survey](https://scholariq.org/papers/healthcare-resource-utilization-at-different-stages-of-amyotrophic-lateral/)
- [EE48 Healthcare Resource Utilization (HCRU), Quality of Life (QoL), and Employment Changes for Early, Middle and Late-Stage People with Amyotrophic Lateral Sclerosis (pALS) in Italy: Results from a Real-World Survey](https://scholariq.org/papers/ee48-healthcare-resource-utilization-hcru-quality-of-life-qol-and-employment/)

## Researcher topics

- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Schizophrenia research and treatment](https://scholariq.org/topics/schizophrenia-research-and-treatment/)

## Researcher university

- [Adelphi Group (United Kingdom)](https://scholariq.org/institutions/adelphi-group-united-kingdom/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.